课题基金 / 基金详情

PHASE 1 TRIAL OF HSVTR GENE THERAPY FOR CNS TUMORS

PHASE 1 TRIAL OF HSVTR GENE THERAPY FOR CNS TUMORS
HSVTR 基因治疗中枢神经系统肿瘤的一期试验
批准号:
6244467
负责人:
JANE B ALAVI
金额:
$2.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-17 至 1998-02-28

项目摘要

项目成果

JANE B ALAVI的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to determine the effectiveness and safety of a recombinant (laboratory-produced) adenovirus injected into brain tumors. The virus has been especially designed to carry a gene called herpes simplex thymidine kinase (HSV-TK). The study will investigate whether this gene (a gene is part of the nucleus of a cell) will enter brain tumor cells and make them sensitive to the killing effect of the drug ganciclovir.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO
  • 批准号:
    6565778
  • 项目类别:
  • 资助金额:
    $12.41万
  • 财政年份:
    2001
  • 负责人:
    JANE B ALAVI
  • 依托单位:
UPCC7399: PYRAZOLACRIDINE IN ADULTS W NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
  • 批准号:
    6565856
  • 项目类别:
  • 资助金额:
    $12.41万
  • 财政年份:
    2001
  • 负责人:
    JANE B ALAVI
  • 依托单位:
UPCC8399: ORAL PROCARBAZINE IN TREATMENT OF RECURRENT HIGH GRADE ASTROCYTOMA
  • 批准号:
    6565857
  • 项目类别:
  • 资助金额:
    $12.41万
  • 财政年份:
    2001
  • 负责人:
    JANE B ALAVI
  • 依托单位:
CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE
  • 批准号:
    6565798
  • 项目类别:
  • 资助金额:
    $12.41万
  • 财政年份:
    2001
  • 负责人:
    JANE B ALAVI
  • 依托单位: